ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Carolina » Rheumatology

Top Rheumatology Prescribers in South Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWIN MARTINEZ DE ANDINO M.D.

Rheumatology

16,628

$1.08M

511
397 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $128

KEVIN TRACY MD

Rheumatology

11,554

$971K

554
250 are 65+

35%
patients receiving schedule two controlled substances

Avg: 6%

53%
patients receiving schedule three controlled substances

Avg: 13%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 23%

$84
Average prescription price

Avg: $128

ROBERT TURNER MD

Rheumatology

11,342

$1.31M

495
261 are 65+

29%
patients receiving schedule two controlled substances

Avg: 6%

36%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$115
Average prescription price

Avg: $128

SUPEN PATEL MD

Rheumatology

9,646

$1.17M

691
383 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

40%
patients receiving schedule three controlled substances

Avg: 13%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 23%

$121
Average prescription price

Avg: $128

J DOCHERTY MD

Rheumatology

8,964

$1.19M

656
412 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$133
Average prescription price

Avg: $128

AMIR AGHA MD

Rheumatology

6,602

$772K

845
461 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 13%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$117
Average prescription price

Avg: $128

WENDY LEE MD

Rheumatology

6,582

$653K

408
255 are 65+

22%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$99
Average prescription price

Avg: $128

MUTHAMMA MACHIMADA MD

Rheumatology

5,718

$555K

394
171 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$97
Average prescription price

Avg: $128

MELISSA TERCHEK MD

Rheumatology

5,545

$721K

373
213 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$130
Average prescription price

Avg: $128

JON TWINING MD

Rheumatology

5,534

$702K

365
224 are 65+

28%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$127
Average prescription price

Avg: $128

DAVID BURACK MD

Rheumatology

5,039

$496K

448
308 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$98
Average prescription price

Avg: $128

FRANK HARPER MD

Rheumatology

4,897

$459K

342
202 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

32%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$94
Average prescription price

Avg: $128

JOHN BRITTIS MD

Rheumatology

4,494

$728K

548
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 23%

$162
Average prescription price

Avg: $128

GARY FINK M.D.

Rheumatology

4,220

$242K

271
168 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $128

DAVID HOLT MD

Rheumatology

4,045

$295K

301
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 23%

$73
Average prescription price

Avg: $128

GREGORY NIEMER M.D.

Rheumatology

3,901

$602K

294
137 are 65+

19%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$154
Average prescription price

Avg: $128

ALLISON LIPSEY MD

Rheumatology

3,737

$679K

330
245 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$182
Average prescription price

Avg: $128

BRUCE GOECKERITZ MD

Rheumatology

3,580

$366K

347
210 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$102
Average prescription price

Avg: $128

GEORGIA ROANE MD

Rheumatology

3,452

$466K

272
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$135
Average prescription price

Avg: $128

MITCHELL FEINMAN M.D.

Rheumatology

3,348

$497K

343
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$148
Average prescription price

Avg: $128

DOUGLAS CONAWAY M.D.

Rheumatology

3,347

$580K

422
304 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 23%

$173
Average prescription price

Avg: $128

DEBORAH MEADOWS MD

Rheumatology

3,244

$462K

263
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 13%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$142
Average prescription price

Avg: $128

SUNEETHA MORTHALA M.D.

Rheumatology

2,936

$484K

307
167 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 13%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 23%

$165
Average prescription price

Avg: $128

EDWIN SMITH MD

Rheumatology

2,818

$300K

218
121 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$107
Average prescription price

Avg: $128

JAMES HALLA M.D.

Rheumatology

2,784

$648K

365
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$233
Average prescription price

Avg: $128

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank